• What is Osteoporosis?
     

    What is Osteoporosis?

    An estimated 150 million people worldwide have osteoporosis leaving them at risk for the first-time. Due to its prevalence worldwide, osteoporosis is considered as a serious public health concern. Currently it is estimated that over 200 million people worldwide suffer from this disease1. Approximately 30% of all postmenopausal women have […]

    Read full article

  • Prescreening Tools to Determine Who Needs DXA
     

    Prescreening Tools to Determine Who Needs DXA

    Elliott N. Schwartz, MD, CCD, CPD, and Dee M. Steinberg, XT, CDT Clinical decision rules (CDRs) are designed to help physicians practice better. A number of CDRs to assist in identifying women with low bone mass have been developed since the mid 1990s, including SCORE, OST (OSTA), OSIRIS, SOFSURF, NOF, […]

    Read full article

  • Teriparatide in postmenopausal women with osteoporosis and mild or moderate renal impairment.
     

    Teriparatide in postmenopausal women with osteoporosis and mild or moderate renal impairment.

    Miller PD, Schwartz EN, Chen P, Misurski DA, Krege JH. INTRODUCTION: The prevalence of both osteoporosis and renal impairment increases with age. METHODS: Using data from the Fracture Prevention Trial, the safety and efficacy of teriparatide [rhPTH(1-34)] in postmenopausal women with osteoporosis and renal impairment were explored.

    Read full article

 
 
 

Sign up for a FREE newsletter.

* Get breaking medical news and clinical perspectives on Osteoporosis & Skeletal health.
* Unlimited access to the Annual Meeting medical education course videos.

The Northern California Institute for Bone Health, Inc., is dedicated to detection of bone loss and improvement in treatment utilizing bone density testing, clinical research and education of physicians, allied health professionals and the general public.  Join us!